Compare Humana Inc (HUM) vs PayPal Holdings, Inc. (PYPL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs PayPal Holdings, Inc. — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while PayPal Holdings, Inc. trades at $55.53 (market cap $47.07B). The key difference: Humana Inc and PayPal Holdings, Inc. are close in size by market cap, and PayPal Holdings, Inc. pays the higher dividend (1.02%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and PayPal Holdings, Inc. for 106 Days on average.
| HUM | PYPL | |
|---|---|---|
Market Cap | $46.49B | $47.07B |
Volume | 2,567,704 | 13,860,099 |
Sector | Health | Financials |
52-Week High | $431.03 | $73.01 |
52-Week Low | $163.67 | $39.08 |
Typical Hold Time | 51 Days | 106 Days |
Enterprise Value | $53.84B | $49.21B |
Dividend Yield | 0.91% | 1.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
PayPal trades at $55.02, up 0.13% with a bullish technical signal from moving averages. The stock shows strong fundamentals with a P/E of 10.4, net margin of 14.36%, and recent earnings beats. Recent partnerships with Meta and cost-cutting initiatives under new CEO Enrique Lores are driving positive sentiment. Cash flow remains healthy with $1.53B net cash flow in 2025.
PayPal presents a value opportunity with attractive valuation metrics and improving operational efficiency. Key risks include checkout competition and slowing growth in branded solutions. Analyst consensus leans cautious with 60% hold ratings, though the $56.41 price target suggests modest upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About PayPal Holdings, Inc.
PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →
